Dr. Dharma Ram Poonia ๐Ÿ‡ฎ๐Ÿ‡ณ (@drdharmapoonia) 's Twitter Profile
Dr. Dharma Ram Poonia ๐Ÿ‡ฎ๐Ÿ‡ณ

@drdharmapoonia

Associate Professor- Surgical Oncology @AIIMS_Jodhpur,
Section Editor of Head n Neck Oncology @IASO_IJSOonline

ID: 557168064

linkhttp://AIIMsjodhpur.edu.in calendar_today18-04-2012 18:01:02

819 Tweet

261 Followers

741 Following

IASO-IJSO online (@iaso_ijsoonline) 's Twitter Profile Photo

#callforauthors IJSO invites oncologist, surgeons and young scientist to submit their abstract in renowned pubmed indexed journal. #bigopportunity #freeofcost link.springer.com/journal/13193

#callforauthors
IJSO invites oncologist, surgeons and young scientist to submit their abstract in renowned pubmed indexed journal. 
#bigopportunity #freeofcost

link.springer.com/journal/13193
CTSNet (@ctsnetorg) 's Twitter Profile Photo

Abdominal Phase of McKeownโ€™s Esophagectomy: Laparoscopic D2 Dissection for Esophageal Cancer This excellent video from @ drdharmapoonia demonstrates the abdominal phase of McKeownโ€™s esophagectomy, which involves a laparoscopic D2 lymphadenectomy. ๐Ÿ”—ow.ly/m6bJ50X5QJk

Abdominal Phase of McKeownโ€™s Esophagectomy: Laparoscopic D2 Dissection for Esophageal Cancer  

This excellent video from @ drdharmapoonia demonstrates the abdominal phase of McKeownโ€™s esophagectomy, which involves a laparoscopic D2 lymphadenectomy.  

๐Ÿ”—ow.ly/m6bJ50X5QJk
IGCS (@igcsociety) 's Twitter Profile Photo

Ovarian Cancer Master Session | IGCS 2025 A powerhouse session dedicated to advancing ovarian cancer care. Expect expert perspectives, new strategies, and multidisciplinary dialogue on one of the most critical areas in gynecologic oncology. ๐Ÿ“… Fri, Nov 7, 2025 ๐Ÿ•’ 09:15 โ€“ 10:45

Ovarian Cancer Master Session | IGCS 2025
A powerhouse session dedicated to advancing ovarian cancer care. Expect expert perspectives, new strategies, and multidisciplinary dialogue on one of the most critical areas in gynecologic oncology.

๐Ÿ“… Fri, Nov 7, 2025
๐Ÿ•’ 09:15 โ€“ 10:45
NEJM (@nejm) 's Twitter Profile Photo

In intermediate-risk breast cancer, postmastectomy chest-wall irradiation did not improve 10-year overall survival as compared with no chest-wall irradiation. Full SUPREMO phase 3 trial results: nej.md/3Jxd3sI Editorial: Omission of Chest-Wall Irradiation after

In intermediate-risk breast cancer, postmastectomy chest-wall irradiation did not improve 10-year overall survival as compared with no chest-wall irradiation. Full SUPREMO phase 3 trial results: nej.md/3Jxd3sI 

Editorial: Omission of Chest-Wall Irradiation after
Dr. Dharma Ram Poonia ๐Ÿ‡ฎ๐Ÿ‡ณ (@drdharmapoonia) 's Twitter Profile Photo

SUPREMO, further De-escalation. NEJM IASO-IJSO online Large European Trial The University of Edinburgh Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer | New England Journal of Medicine nejm.org/doi/full/10.10โ€ฆ